Home
|
Press
|
Events
|
Eshare
Sign in
/
Register
0
Shopping Cart
X
Close
My Products (0 items)
My shopping cart is empty.
.
Sign in
/
Register
X
Close
Login/Register
Email
Password
INDUSTRIES
Agriculture
Chemicals
Food & Feed
Pesticides
Titanium Dioxide (TiO2)
Dairy Products
Full Industry List
ONLINE DATABASE
PRODUCTS & SERVICE
Products' Introduction
Industrial Reports
Newsletters
Market Data
Content Byte
Agrochemical Regulatory
Customized solutions
IMPACT FACTOR
MARKET NEWS
Agriculture
Chemicals
Food & Feed
Other
ABOUT
About CCM
Why CCM?
CCM Story
CCM Clients
Events
Career
Company news
CONTACT
Home
Product
Newsletters
>
广济药业拟定增募资首次涉足维生素B12生产
Read online
广济药业拟定增募资首次涉足维生素B12生产
摘要:2月27日,广济药业发布"2019年度非公开发行A股股票预案",拟募集资金总额不超过50,000万(USD74.67 million),用于维生素B2现代化升级与安全环保技术改造项目、年产1,000吨(1%)维生素B12综合利用项目,以及补充流动资金。2月27日,湖北广济药业股份有限公司(广济药业)发布"2019年度非公开发行A股股票预案"。根据预案,广济药业拟非公开发行股票不超4,974.20万股,募集资金总额不超过50,000万元(USD74.67 million)。扣除发行费用后,募...
Vitamins China E-News 201903(Chinese version)
Add to DIY report
Select whole article
I haven't create reports,
create a new report
right now!
Recommend Newsletters
Crop Farming in China
2016/05/31
More>>
Report on Glyphosate Business Opportunities Worldwide
2016/07/27
More>>
Specialised Control and Prevention of Pests and Diseases for Crops in China
2016/07/12
More>>
Loading...